Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9218)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2018 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang YK, Shen L, Jiao X, Zhang XT. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP. World J Gastroenterol 2018; 24(2): 266-273 [PMID: 29375212 DOI: 10.3748/wjg.v24.i2.266] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i2/266.htm |
| Number | Citing Articles |
| 1 |
Xiang Xu, Qing Wang, Huihua Cao, Zhenyan Gao, Guangyang Qian, Qicheng Lu, Yugang Wu. Prognostic value of serum alpha-fetoprotein levels in patients with gastric cancer: a meta-analysis. Journal of International Medical Research 2020; 48(3) doi: 10.1177/0300060519899780
|
| 2 |
Xiaohuan Tang, Ting Guo, Xiaolong Wu, Xuejun Gan, Yiding Wang, Fangzhou Jia, Yan Zhang, Xiaofang Xing, Xiangyu Gao, Ziyu Li. Clinical Significance and Immune Infiltration Analyses of the Cuproptosis-Related Human Copper Proteome in Gastric Cancer. Biomolecules 2022; 12(10): 1459 doi: 10.3390/biom12101459
|
| 3 |
Nan Jiang, Tian Tian, Xianyang Chen, Guofen Zhang, Lijie Pan, Chengping Yan, Guoshan Yang, Lili Wang, Xuchen Cao, Xin Wang, Dan Zhao. A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/5579373
|
| 4 |
Takayo Ota, Katsuya Sakashita, Ryugo Sawada, Kurumi Seki, Hiroyuki Maeda, Noriko Tanaka, Toshimasa Tsujinaka. Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature. Surgical Case Reports 2023; 9(1) doi: 10.1186/s40792-023-01653-4
|
| 5 |
Daisaku Kamiimabeppu, Takeru Wakatsuki, Daisuke Takahari, Naoki Fukuda, Keitaro Shimozaki, Hiroki Osumi, Izuma Nakayama, Mariko Ogura, Akira Ooki, Eiji Shinozaki, Keisho Chin, Kensei Yamaguchi. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer. International Journal of Clinical Oncology 2023; 28(1): 121 doi: 10.1007/s10147-022-02263-0
|
| 6 |
Ting Deng, Feixue Wang, Le Zhang, Tao Ning, Yansha Sun, Shaohua Ge, Ming Bai, Yao Lu, Hongli Li, Yi Ba. Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study. Cancer Immunology, Immunotherapy 2024; 73(8) doi: 10.1007/s00262-024-03743-0
|
| 7 |
Lu Zhang, Yan-Ping Chen, Min Ji, Le-Qian Ying, Chun-Chun Huang, Jing-Yi Zhou, Lin Liu. Inflammation-related markers and prognosis of alpha-fetoprotein producing gastric cancer. World Journal of Gastrointestinal Oncology 2024; 16(9): 3875-3886 doi: 10.4251/wjgo.v16.i9.3875
Abstract(234) |
Core Tip(243) |
Full Article(HTML)(1310)
|
Full Article with Cover (PDF)-1413K(53)
|
Audio-1222K(2)
|
Peer-Review Report-170K(36)
|
Answering Reviewers-63K(39)
|
Supplementary Material-502K(41)
|
Full Article (PDF)-1138K(76)
|
Full Article (XML)-137K(44)
|
Times Cited (0)
|
Total Visits (3077)
|
Open
|
| 8 |
Rihui Su, Ling Xia, Gongke Li, Xiaohua Xiao. A controlled recognizing and releasing glycoprotein based on temperature-responsive phenylboronic microgels for colorimetric analysis of complex samples. Talanta 2022; 241: 123260 doi: 10.1016/j.talanta.2022.123260
|
| 9 |
Binjie Huang, Feifei Ding, Yumin Li. A practical recurrence risk model based on Lasso-Cox regression for gastric cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(17): 15845 doi: 10.1007/s00432-023-05346-1
|
| 10 |
晫煦 任. Progress of Alpha-Fetoprotein-Positive in Non-Hepatic Digestive System Tumors. Advances in Clinical Medicine 2022; 12(11): 10753 doi: 10.12677/ACM.2022.12111549
|
| 11 |
Yanli He, Haijun Lu, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Progress in Molecular Biology and Translational Science 2019; 162: 199 doi: 10.1016/bs.pmbts.2019.01.001
|
| 12 |
Liyu Wang, Ying Feng, Anquan Huang, Jianming Shi, Qinying Zhang, Fan Zhu, Bin Lv, Fen Guo, Tianming Zou, Luyao Zhang. Case report: Significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.962126
|
| 13 |
Ruhan Wang, Jing Li, Dan Xu, Ruiyang Li, Ping Gong. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer. Medicine 2020; 99(47): e23326 doi: 10.1097/MD.0000000000023326
|
| 14 |
Ningning Li, Chunmei Bai, Ruixing Zhang, Liwen Ma, Xiubao Ren, Junping Zhang, Zhanzhao Fu, Lin Zhao. Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer. Translational Oncology 2021; 14(2): 101004 doi: 10.1016/j.tranon.2020.101004
|
| 15 |
Wei Li, Qian Li, Yiyi Yu, Yan Wang, Erbao Chen, Lingli Chen, Zhiming Wang, Yuehong Cui, Tianshu Liu. <p>Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma</p>. Cancer Management and Research 2020; : 11113 doi: 10.2147/CMAR.S276969
|
| 16 |
Xin-yu Li, Shou-lian Wang, De-hu Chen, Hui Liu, Jian-Xiong You, Li-xin Su, Xi-tao Yang. Construction and Validation of a m7G-Related Gene-Based Prognostic Model for Gastric Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.861412
|
| 17 |
Uğuray Aydos, Gözde Tahtaci, Ümit Özgür Akdemir, Ahmet Özet. 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters. Nuclear Medicine Communications 2020; 41(11): 1199 doi: 10.1097/MNM.0000000000001272
|
| 18 |
Xiang-Xing Kong, Xin-Lin Li, Yu Tian, Qian-Cheng Ye, Xiao-Ming Xu, Yue Liu, Qi Yang, Li-Na Zhang, Yan-Xia Mei, Ji-Hang Wen, Qian Xiao, Jing-Song Li, Ke-Feng Ding, Jun Li. The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract—A Single-Center Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.635537
|
| 19 |
Yichao Wang, Guangyu Ding, Chu Chu, Xiang-Dong Cheng, Jiang-Jiang Qin. Genomic biology and therapeutic strategies of liver metastasis from gastric cancer. Critical Reviews in Oncology/Hematology 2024; 202: 104470 doi: 10.1016/j.critrevonc.2024.104470
|
| 20 |
Yingying Chen, Wei Yang, Lifang Ye, Suzhen Lin, Kuangyi Shu, Xiao Yang, Xinyi Ai, Yating Yao, Minghua Jiang. Economical and Easily Detectable Markers of Digestive Tumors: Platelet Parameters. Biomarkers in Medicine 2021; 15(3): 157 doi: 10.2217/bmm-2020-0203
|
| 21 |
Yakun Wang, Jialin Lu, Xiaoyi Chong, Chang Wang, Xiaofeng Chen, Zhi Peng, Yanhong Gu, Yizhuo Wang, Xicheng Wang, Jian Li, Jifang Gong, Changsong Qi, Jiajia Yuan, Zhihao Lu, Ming Lu, Jun Zhou, Yanshuo Cao, Yang Chen, Cheng Zhang, Zhiguo Hou, Hongyi Kou, Lin Shen, Xiaotian Zhang. PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02193-z
|
| 22 |
Yuriko Takayama-Isagawa, Kengo Kanetaka, Shinichiro Kobayashi, Akira Yoneda, Shinichiro Ito, Susumu Eguchi. High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54394-1
|
| 23 |
Ghazaleh Khalili-Tanha, Nima Khalili-Tanha, Arian Karimi Rouzbahani, Ramisa Mahdieh, Kimia Jasemi, Rosa Ghaderi, Fatemeh Khojasteh Leylakoohi, Elnaz Ghorbani, Majid Khazaei, Seyed Mahdi Hassanian, Ibrahim Saeed Gataa, Gordon A Ferns, Elham Nazari, Amir Avan. Diagnostic, prognostic, and predictive biomarkers in gastric cancer: from conventional to novel biomarkers. Translational Research 2024; 274: 35 doi: 10.1016/j.trsl.2024.09.001
|
| 24 |
Kecheng Zhang, Lin Chen. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920904803
|
| 25 |
Ting Pang, Qiulian Tang, Jiangcun Wei, Junxuan Li, Liuhui Ma, Qingxia Qin, Jiabao Ma, Huan He, Yong Chen. Construction of a novel immune-related prognostic-predicting model of gastric cancer. Gene 2023; 852: 147032 doi: 10.1016/j.gene.2022.147032
|